United States · FDA National Drug Code directory
Levothyroxine Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0615-8651_4caa5e76-0e12-4c19-9cc7-af7365f7dc90
- Product NDC
- 0615-8651
- Form
- TABLET
- Composition / generic term
- Levothyroxine Sodium
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Marketing category
- NDA
- Marketing start / end (source format)
- 20031201
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — .175 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 TABLET in 1 BLISTER PACK (0615-8651-14) · 0615-8651-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →